X
Email:
sales@ruixibiotech.com
Products classification
ABOUT US
Email:
sales@ruixibiotech.com
Tel.:
02988811435
Home > products > custom-nanocomposites > nanopeptides > s2p-crtltvrkc-plga-maleimide-peg2k-nanoparticles-containing-imatinib

S2P(CRTLTVRKC)-PLGA-Maleimide-PEG2k nanoparticles containing Imatinib

S2P peptide-conjugated PLGA-Maleimide-PEG2000 nanoparticles containing Imatinib

Catalog # Pkg Size Price(USD) Quantity Buy this product
R-M2-9507 1EA inquiry

Product description

S2P peptide-conjugated PLGA-Maleimide-PEG nanoparticles/S2P(CRTLTVRKC)-PLGA-Maleimide-PEG2k nanoparticles containing Imatinib    containing Imatinib for targeting drug delivery to atherosclerotic plaques.Stabilin-2 peptide with sequence of CRTLTVRKC is a specific ligand to stabilin-2,so it was synthesized for using as the targeting agent for atherosclerosis. 


Appearance Freeze-dried powder
Molecular weight N/A
Nano size 183nm
Solubility N/A
S2P sequence CRTLTVRKC
Loading capacity of nanoparticles loaded with Imatinib 5.05%
the percentage of S2P peptide in nanoparticles 1.3%
Storage -20℃, protected from light and moisture
Transportation 4-25℃ temperature for up to 3 weeks
Stability 1 year
Document

msds of S2P(CRTLTVRKC)-PLGA-Maleimide-PEG2k nanoparticles containing Imatinib
Related Product